NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE5910 Query DataSets for GSE5910
Status Public on Sep 27, 2006
Title Octreotide LAR and the oxyntic mucosa
Organism Rattus norvegicus
Experiment type Expression profiling by array
Summary Previous studies have shown that treatment with the somatostatin analogue octreotide LAR causes regression of gastric ECL-cell carcinoids in patients with hypergastrinaemia due to chronic atrophic gastritis, reducing both the number and size of tumours. The main objective of the present study was to examine the molecular mechanisms behind the antiproliferative effect of octreotide in the oxyntic mucosa on a genome wide scale. Female Sprague-Dawley rats were dosed with octreotide LAR and control group were given the LAR vehicle for 21 days. Serum gastrin levels were measured and tissue samples for histology and RNA extraction collected from the oxyntic mucosa. Histomorphological examination showed a significant decrease in the number of gastric glands, cells per gland and length of glands, indicating a negative effect of octreotide on growth of the oxyntic mucosa. Further immunohistochemical studies showed a tendency towards increased apoptosis and decreased proliferation in the group receiving octreotide. Affymetrix GeneChip microarrays were used to detect differentially expressed genes. Many regulated genes could be related to regulation of apoptosis, fewer to proliferation, and the largest group of regulated genes was transcriptional factors several of which may be involved in regulation of growth. Control studies using quantitative real-time RT-PCR showed a high degree of consistency of the microarray results. In conclusion, octreotide exerts a negative effect on growth of the oxyntic mucosa, and extensive gene expression changes relevant to growth regulation can be detected.
Keywords: regulation, proliferation, Affymetrix GeneChip, qRT-PCR, immunohistochemistry.
 
Overall design RNA from eigth animals (controls that received the LAR-vehicle) were pooled to produce a control affymetrix chip. Six animals (treatmentgroup) were given octreotide LAR and RNA from two and two animals were pooled to produce three affymetrix chips for comparison to the controlchip.
 
Contributor(s) Erlandsen SE, Fykse V, Waldum HL, Sandvik AK
Citation(s) 17210224, 10700043
Submission date Sep 26, 2006
Last update date Mar 03, 2017
Contact name Sten Even Erlandsen
E-mail(s) sten.e.erlandsen@ntnu.no
Phone 004799526568
Organization name NTNU
Department Department of Cancer Research and Molecular Medicine
Street address Olav Kyrres gate 9, 5 etg.
City Trondheim
ZIP/Postal code 7489
Country Norway
 
Platforms (1)
GPL341 [RAE230A] Affymetrix Rat Expression 230A Array
Samples (4)
GSM137338 Oxyntic mucosa_LAR-vehicle_21-days_rep1
GSM137339 Oxyntic mucosa_Octreotide LAR_21-days_rep1
GSM137340 Oxyntic mucosa_Octreotide LAR_21-days_rep2
Relations
BioProject PRJNA97347

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE5910_RAW.tar 9.2 Mb (http)(custom) TAR (of CEL, EXP)

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap